Navigation Links
Scientific hunch poised to save thousands from toxic fish poisoning
Date:10/21/2008

A neuroscientist at UQ's Queensland Brain Institute has found a way to combat a debilitating illness that affects an estimated 50,000 people a year in tropical regions.

Ciguatera poisoning which often results in acute nausea, vomiting and painful gastrointestinal episodes is caused by eating fish that have fed on a micro algae that are toxic to mammals and often associated with large algal blooms known as red tides.

Cases of ciguatera poisoning have been documented for more than 200 years and were recorded and described by Captain Cook on his second voyage to the Pacific in 1774.

Recently, scientists have discovered that the patented compound brevenal could be used to make an effective treatment for neurotoxic shellfish poisoning (NSP), a condition related to ciguatera poisoning.

Acting initially on a hunch, QBI neuroscientist Associate Professor Fred Meunier hypothesised that brevenal could be adapted to combat ciguatera poisoning.

Simultaneously, and unbeknown to Dr Meunier, Dr Dan Baden at the University of North Carolina Wilmington (USA) was also considering adapting brevenal to fight ciguatera.

The two scientists soon became aware of each other's interest and began discussing the possibility that the compound active against NSP could have the same therapeutic effect on ciguatera toxins.

Along with Dr Dan Baden, Dr Jordi Molgo (National Center For Scientific Research, France) and Dr Richard Lewis at UQ's Institute for Molecular Bioscience, Dr Meunier pressed on to obtain a small batch of both ciguatera toxin and brevenal to test their hypothesis.

"It now seems that we have found a way of blocking the effect of the ciguatera toxin on sodium channels without affecting their function of propagating the electrical signals in neurons," Dr Meunier said.

One of the main problems with ciguatera is that there are few, if any, effective treatments for the acute impact it has
'/>"/>

Contact: QBI Communications
r.hohen@uq.edu.au
61-733-466-414
Research Australia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Thomson Scientific Predicts Nobel Laureates
3. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
4. Thomson Scientific Announces BONDplus for Biological Researchers
5. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
6. International Society of Hair Restoration Surgery Hosts 15th Annual Scientific Meeting in Las Vegas, September 26-30, 2007
7. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
8. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
9. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
10. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
11. Delta Dental Plans Association Forms National Scientific Advisory Committee

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewsw...sdaq: SHMR ) ( "Shamir" ), a leading provider of ...ic lens market, announced today that its board of ...an aggregate amount of US$ 10 million (approximate...9 representative rate of exchange), or approximate...
(Date:11/27/2009)... Voyant Health™ anno...chigan) has licensed its TraumaCad Enterprise orth...d workflow solution. , (P...nounced today that Spectrum Health (Grand Rapids, ...thopedic templating solution and its TraumaCad Ext...
(Date:11/26/2009)..., , PRINCETON, N.J., Nov. 27 /PRNewswire/...ill almost double over the next 25 years and annua...hit $336 billion, up from $113 billion today, acco...f Diabetes Care . The National Changing Diabete..., commissioned the analysis by a team from the Uni...
(Date:11/26/2009)... No more letters from the ...,personalized text messages from Santa , ...fort to increase operational efficiencies at the N... to help keep children all over the globe informed...Elves in Santa’s research department have id...
(Date:11/25/2009)..., , EDINA, Minn., Nov. 25 /PRNewswire-USNew...hey think of their dentist. But a chiropractor ca...s for the Temporal-Mandibular Joint, which is wher...skull (temporal bone). ,, The most common symp... chewing, clicking or popping of the jaw. But man...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...ACH, Calif., June 25 Function Drinks,announced to...NIGHT LIFE, a,physician,s take on supporting sexua...xtract macuna pruriens and the amino acid, tyrosin...d,cnidium help support healthy circulation. Functi...
...ati, OH, June 25, 2008--Bassinet use in 2006 was n...more than 45% of infants between the ages of 0-2 m...ety. In fact, the Consumer Product Safety Commiss...of Pediatrics (AAP) revised its recommendations fo...
...DOVA, Calif., June 24 Executive,Director, Diana F...s who,need financial assistance to help them pay f...ademic year State Nursing Assumption Program of Lo...ces to help them pay for their postsecondary educa...
...on could mean fewer shots for 4 to 6 year-olds in ...e (NYSE:,GSK) announced today that the U.S. Food a...M) [Diphtheria and Tetanus Toxoids and Acellular P...lio,diseases in one shot., "Children 4 to 6 years...
...Y, Mo., June 24 DST Systems, Inc.,(NYSE: DST ) w...uarter,ending June 30, 2008, on Tuesday, July 22, ...tock Exchange., The Company will host a conferenc...arnings Release. For international,callers, the di...
...a., June 24 Alan J. Zuccari,President & CEO of Ha...,Action Committee (PAC) member for the American He...k with the committee., "It,s an honor to be recog...are.", Below is the article which will be feature...
Other Medicine News:Health News:Function Drinks Launches New Product to Support Sexual Health 2Health News:Bedsharing and bassinets: 2 new studies assess the risks 2Health News:Nursing Loan Forgiveness Programs -- More Applicants Needed by June 30, 2008 2Health News:FDA Approves KINRIX(TM) - New Combination Vaccine for Children 2Health News:FDA Approves KINRIX(TM) - New Combination Vaccine for Children 3Health News:DST Systems, Inc. Announces Notification of Earnings Release Date 2Health News:Alan J. Zuccari Featured by the American Health Care Association as a June PAC Member 2
(Date:11/25/2009)....C., Nov. 25 Cempra Pharmaceutical... president and chief executive officer, will prese...nference at 8:50 a.m. EST, December 1, 2009, at Th...nandes will provide an overview of the company,s t...eatment of drug-resistant pathogens including MRSA...
(Date:11/25/2009)...Netherlands and JOHANNESBURG, November 25 /PRNewsw...and Pyxis Discovery announced today,that they have...t both,companies, services. , Pyxis,s wor...y expertise,will be coupled with iThemba,s service...stry support to projects identified through Pyxis,...
(Date:11/24/2009)... Md., Nov. 24 /PRNewswire-Asia/ -- Chindex Interna...ng independent American provider of Western,health...c of China, today,announced that the Company will ...ealth Care Conference, to be held December 1 - 2, ...agement is currently scheduled to present at 11:30...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2Pharmavite Pilots LearnSomething Interactive Digital Signage to Reach Shoppers in Stores 55983 1Pharmavite Pilots LearnSomething Interactive Digital Signage to Reach Shoppers in Stores 55983 2Pharmavite Pilots LearnSomething Interactive Digital Signage to Reach Shoppers in Stores 55983 3VisEn Launches New Annexin Vivo 750 Fluorescence Molecular Imaging Agent 13792 1VisEn Launches New Annexin Vivo 750 Fluorescence Molecular Imaging Agent 13792 2VisEn Launches New Annexin Vivo 750 Fluorescence Molecular Imaging Agent 13792 3Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 1Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 2Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 3Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 4Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 5
...ts with multiple sclerosis, remained relapse-fre...- New data demonstrate 89% of patients free from a...S - three years after starting treatment, - MS, a...y, affects 2.5 million people worldwide i...lings planned before end of 2009 in US and EU, EA...
...sis of methotrexate,resistance and differences in ...The first analysis,of the genetic determinants of ... childhood acute lymphoblastic leukemia (ALL) coul...d treatments to overcome it,according to a St. Jud...s use in ALL, methotrexate is widely used to treat...
Other Medicine Technology:FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 2FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 3FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 4FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 5FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 6St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia 2St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia 3St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia 4
ExcaliburPlus PC, 220V, 50Hz
Elmed BC 50 Standard
Hudson Burr
Cushing Burr
Medicine Products: